Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1995;76:335-342

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yatani, A.
Right arrow Articles by Green, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yatani, A.
Right arrow Articles by Green, S.
(Circulation Research. 1995;76:335-342.)
© 1995 American Heart Association, Inc.


Articles

Stable Expression and Coupling of Cardiac L-Type Ca2+ Channels With ß1-Adrenoceptors

Atsuko Yatani, Minoru Wakamori, Tetsuhiro Niidome, Satoshi Yamamoto, Isao Tanaka, Yasuo Mori, Kouich Katayama, Stuart Green

From the Departments of Pharmacology and Cell Biophysics (A.Y., M.W., S.Y., Y.M.) and Medicine (Pulmonary) (A.Y., S.G.), University of Cincinnati (Ohio) College of Medicine, and Tsukuba Research Laboratories (T.N., I.T., K.K.), Eisai Co Ltd, Ibaraki, Japan.

Correspondence to Dr A. Yatani, Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract A number of neurotransmitters modulate cardiac dihydropyridine-sensitive L-type Ca2+ channels through several homologous G protein–coupled receptors. Previous studies that have examined receptor–Ca2+ channel interactions have suffered because of the coexpression of various receptor subtypes in native cells. To study the functional coupling of a particular receptor subtype to these channels, rabbit cardiac Ca2+ channel {alpha}1 and skeletal ß and {alpha}2/{delta} subunits were stably expressed in baby hamster kidney cells. In this stable cell line, Ca2+ channels remained at high levels (>1000 fmol/mg protein, or 2700 channels per cell) over extended times. The expressed recombinant Ca2+ channels displayed the voltage dependence of activation and inactivation, unitary conductance, and pharmacology characteristic of native cardiac L-type Ca2+ channels. Subsequent coexpression of the ß1-adrenoceptors (150 to 300 fmol/mg protein) with the Ca2+ channels resulted in cell responsiveness to the extracellular application of isoproterenol. These results indicate that heterogeneous expression in mammalian cells provides a useful system for studying both biophysical analysis of Ca2+ channel properties and receptor-coupled regulatory processes.


Key Words: Ca2+ channels • ß1-adrenoceptors • patch clamp • baby hamster kidney cells


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The dihydropyridine (DHP)-sensitive L-type Ca2+ channel is one of the main targets of various physiological modulators in cardiac myocytes. ß-Adrenergic agonists such as isoproterenol (Iso) increase L-type Ca2+ channel currents through cytoplasmic cAMP-dependent phosphorylation and also via a membrane-delimited direct interaction with the stimulatory G protein (Gs).1 2 3 4 5 6 Evidence from radioligand binding and functional studies indicates that both ß1- and ß2-adrenoceptors (ß1AR and ß2AR, respectively) coexist in heart preparations of many mammalian species including human and are functionally involved in the regulation of contractile force and/or heart rate.7 A combination of subtype-specific agonists and antagonists have been used to analyze the cardiotropic effects of individual ßAR subtypes.8 9 However, quantitative studies of the ßAR subtype–specific interactions with cardiac Ca2+ channels are complicated by the coexistence of mixed populations of subtypes in native myocytes, since truly selective activation or blockade of one subtype without effect on the other is difficult to attain.10 Systematic analysis of individual ßAR effects should therefore ideally compare identical cells expressing pure populations of receptor subtypes in a constant biochemical environment.

Structurally, the L-type Ca2+ channel is a complex of four proteins: the {alpha}1 subunit, which contains the binding sites for Ca2+ channel blockers and forms the ion-conducting pore; the {alpha}2/{delta} subunit, a disulfide-linked dimer; the intracellularly located ß subunit; and the transmembrane {gamma} subunit.11 cDNAs for each of the four subunits have been cloned from skeletal muscle. By use of these cDNAs as probes, distinct gene products encoding analogous subunits have been cloned from other tissues, including cardiac muscle. These studies have revealed that the {gamma} subunit is expressed only in skeletal muscle, whereas the {alpha}2/{delta} subunit is highly conserved in most tissues including heart. Expression studies in several systems have also demonstrated that the {alpha}1 subunit is the functional component and determines the pore, gating, and much of the pharmacology of the channel.12

The {alpha}1 and ß subunits of the purified skeletal muscle Ca2+ channel are phosphorylated by cAMP-dependent protein kinase (PKA), with the {alpha}1 subunit appearing to be the primary substrate. In cardiac muscle, however, the target(s) for phosphorylation by PKA is unclear.13 For example, in Xenopus oocytes, cardiac Ca2+ channel currents expressed by recombinant {alpha}1 subunits are not increased by cAMP unless the ß subunit is coexpressed.14 In contrast, Ca2+ channel currents mediated by the {alpha}1 subunit expressed in Chinese hamster ovary (CHO) cells are increased by cAMP-dependent phosphorylation.15 16 These differences may result from the lack of appropriate regulatory components in oocytes. However, the oocyte membrane does contain various amounts of a ß subunit–responsive endogenous Ca2+ channel,17 18 and these are modulated by phosphorylation.19 Such discrepancies have served to render the oocyte expression system particularly problematic for studies of Ca2+ channel regulation. In addition, the presence of extensive infoldings of the oocyte membrane and highly lipophilic compartments within the oocytes reduces effective exchange with bulk solutions used in electrophysiological measurements.20

To circumvent these complications, we stably coexpressed the cDNAs encoding rabbit cardiac {alpha}1,21 skeletal ß,22 and skeletal {alpha}2/{delta}21 subunits in baby hamster kidney (BHK) cells23 and studied adrenergic regulation of the resulting recombinant cardiac Ca2+ channel. BHK cells were selected for study since these cells do not contain detectable endogenous Ca2+ channels or ß-adrenoceptors. In this stable cell line, designated BHKC112, Ca2+ channels remain at high levels without diminution over extended periods (>60 passages) and display gating, conductance, and pharmacology of native L-type cardiac Ca2+ channels. We further show that coexpression of the ß1AR in BHKC112 cells results in Iso-dependent modulation of the expressed Ca2+ currents.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Constructs, Transfections, and Cell Culture
To express a functional cardiac DHP-sensitive Ca2+ channel in a mammalian cell, the following constructs were derived. cDNA encoding the rabbit cardiac {alpha}1 subunit excised from the plasmid pCARD121 was ligated along with the dihydrofolate reductase selection gene derived from pAdD26SV(A)24 into pKCR,25 yielding the plasmid pK4KC. cDNA encoding the rabbit skeletal muscle {alpha}2 subunit derived from pSPCA121 was ligated into pKNH26 to form pCAA2, which includes a neomycin resistance gene. cDNA encoding the rabbit skeletal muscle ß subunit was reverse-transcribed from rabbit skeletal muscle total RNA and then amplified by polymerase chain reaction (PCR) using primers corresponding to nucleotides 80 to 102 (sense) and 1809 to 1835 (antisense) of the rabbit sequence.22 PCR was performed for 35 cycles at 94°C for 1 minute, 68°C for 1 minute, and 72°C for 3 minutes. The {approx}1.8-kb PCR product obtained was subcloned into M13mp18 and mp19 for confirmatory dideoxy sequencing before ligation into pKCRH2,27 yielding the plasmid pCABE.

Stable transfections were performed on BHK cells23 by modified calcium phosphate precipitation (CellPhect, Pharmacia) by using 5 µg each of pK4KC, pCAA2, and pCABE. BHKC112 cells were selected in DMEM containing 600 µg/mL G418 (a neomycin analogue) and 250 nmol/L methotrexate; cells were subsequently maintained in 5% fetal calf serum, 30 µg/mL streptomycin, 30 U/mL penicillin, 80 µg/mL G418, and 250 nmol/L methotrexate. Confirmation of expression of a DHP-sensitive Ca2+ channel was performed by Northern analysis, radioligand binding, and electrophysiological techniques as described below.

BHKC112 cells were transiently transfected with cDNA encoding the human ß1AR by calcium phosphate precipitation similar to that previously described.28 For these transfections, cells were maintained in DMEM supplemented with 10% fetal calf serum, 100 U/mL penicillin, and 100 µg/mL streptomycin. cDNA encoding the human ß1AR excised from the plasmid pBC12BI28 was ligated into the plasmid pcDNA-1/Neo (Invitrogen) under the control of the CMV early promoter, yielding the plasmid pcNeoß1. Plasmid DNA (20 to 40 µg) was used for each transfection. Cells were maintained in DMEM supplemented with 10% fetal calf serum and antibiotics and assayed when confluent (24 to 48 hours). Preliminary data indicated that BHKC112 cells transfected in this manner expressed detectable ß1AR for up to 5 days.

Northern Analysis
Total RNA was isolated from nontransfected BHK cells and from BHKC112 cells by the single-step method of Chomczynski and Sacchi.29 Total RNA (5 µg) was electrophoresed through 1% agarose/formaldehyde gels and transferred to nylon membranes by standard techniques. Double-stranded cDNA probes for the Ca2+ channel {alpha}1, {alpha}2, and ß subunits were prepared from the following sources: {alpha}1, 2.1-kb EcoRI/EcoRV fragment of pCARD321 ; {alpha}2, 2.4-kb HindIII fragment of pSPCA121 ; and ß, 0.8-kb Pst I/Sca I fragment of pCaB2.30 Each probe was then labeled by nick translation. Hybridization was carried out at 42°C overnight, membranes were washed, and autoradiographs were exposed for 72 hours at -70°C.

Radioligand Binding
Ca2+ channel radioligand binding studies were performed by methods similar to those previously described.31 After the cells were washed with Ca2+-free phosphate-buffered saline (PBS), confluent BHKC112 cells in tissue culture dishes were used to prepare crude membranes by mechanical disruption in 5 mmol/L Tris (pH 7.4) and 2 mmol/L EDTA buffer and centrifugation at 39 000g for 10 minutes at 4°C. Saturation binding studies were performed by suspending membranes in assay buffer (50 mmol/L MOPS, pH 7.4) at {approx}30 µg/mL and incubating for 2 hours at 22°C with 0 to 10 nmol/L [3H]PN200-110 in a final volume of 500 µL. Nonspecific binding was defined by 1 µmol/L nitrendipine. Reactions were stopped by dilution and rapid filtration over glass fiber filters, which were then counted in a scintillation counter.

For ßAR radioligand binding studies, membranes were prepared as described above and suspended in 75 mmol/L Tris (pH 7.4), 12.5 mmol/L MgCl2, and 2 mmol/L EDTA at a final concentration of {approx}0.1 mg/mL before incubating with 400 pmol/L [125I]cyanopindolol (ICYP) for 2 hours at 22°C. Reactions were stopped by dilution and rapid filtration over glass fiber filters. Nonspecific binding was defined by 1 µmol/L propranolol. Competition assays were performed similarly, except that incubations were performed in the presence of (final concentrations) 100 µmol/L GppNHp, 30 pmol/L ICYP, and varying amounts of competing ligand as indicated. Both saturation and competition data were analyzed by nonlinear techniques as described previously28 ; Hill coefficients were typically close to 1.0. For all radioligand binding assays, total counts bound were typically <10% of counts added. Protein was measured by a copper bicinchoninic assay,32 with bovine serum albumin used as standard.

cAMP Determinations
Whole-cell cAMP determinations were assessed by radioimmunoassay (RIA) similar to that previously described.33 BHKC112 cells were transfected with ß1AR cDNA as described above; when confluent (24 hours), these were detached with 0.5% trypsin/EDTA and seeded into 24-well culture dishes. Twenty-four to 48 hours later, cells were washed three times with PBS and allowed to warm at 37°C for 10 minutes in 450 µL PBS supplemented with 0.1 mmol/L ascorbic acid. Iso was then added at varying concentrations into duplicate wells, and reactions were terminated 10 minutes later by adding 50 µL of 1N HCl. Aliquots of supernatant were acetylated, and cAMP content was determined by RIA as previously described.33

Electrophysiology
For electrophysiological measurements, cells were seeded onto glass coverslips and incubated in culture medium with fetal calf serum for 1 to 3 days. Cells prepared in this manner were spherical and had diameters of 10 to 20 µm when measured with an eyepiece micrometer at x40 (x600 total magnification). The surface areas of cells were thus between 314 and 1256 µm2, assuming that the cells maintained a smooth spherical shape. Whole-cell and single-channel currents were recorded by patch-clamp techniques as previously described.34 Patch electrodes were coated with Sylgard and had resistances of 2 to 5 M{Omega}. Whole-cell currents were low-pass–filtered (-3 dB) at 0.2 to 1 kHz and digitized at 0.5 to 5 kHz. Leak and capacitative currents were corrected by using a P/4 subtraction procedure unless noted otherwise. The external solution contained (mmol/L) BaCl2 2, MgCl2 1, tetraethylammonium chloride 135, 4-aminopyridine 5, glucose 10, and HEPES 10 (pH 7.3 with Tris base). The pipette solution was (mmol/L) cesium aspartate 110, CsCl 20, MgCl2 2, ATP 2, GTP 0.5, EGTA 5, and HEPES 5 (pH 7.3 with Tris base). The membrane capacitance of the cells was measured by using voltage ramps of 0.8 V/s from a holding potential of -50 mV. The conductance-voltage relation (G/Gmax) was determined by using an interactive nonlinear regression fitting procedure to the Boltzmann equation: G/Gmax=1/{1+exp[(V0.5-Vm)/k]}, where Vm is the membrane potential, V0.5 is the midpoint potential, and k is the slope factor. Similarly, voltage-dependent inactivation (I/Imax) was determined by using the Boltzmann equation: I/Imax= 1/{1+exp[(Vm-V0.5)/k]}.

Single-channel currents were low-pass–filtered at 1 to 2 kHz, digitized at 5 to 10 kHz, and analyzed as previously described.34 The patch electrodes contained (mmol/L) BaCl2 90, glucose 10, and HEPES 10 (pH 7.3 with Tris base). Cells were bathed in a high-KCl depolarizing solution containing (mmol/L) KCl 140, MgCl2 2, EGTA 5, and HEPES 5 (pH 7.3 with KOH). Curve fitting was performed by using a maximum likelihood estimator.

Solution changes were made by using a modification of Y-tube techniques described by Nakagawa et al.35 A microcapillary tube (0.1-mm diameter) was set {approx}200 µm away from the cell being recorded. Solutions were then delivered by a negative pressure of -40 cm Hg. After the pressure was released, external solution was emitted from the outlet of the Y tube by gravity. Complete exchange of the solution surrounding the recording cell can be achieved within 50 milliseconds. To avoid accumulation of test substances in the bulk solution, the chamber was continuously perfused at 5 mL/min.

All experiments were performed at room temperature (20°C to 21°C). Mean±SEM values are given in the text. Comparisons between conditions were evaluated by using Student's t test, with significance imparted at the P<.05 level.

Materials
All radioligands were from New England Nuclear. BHK cells were from American Type Culture Collection. DMEM and fetal calf serum were from JRH Bioscience. G418 was from GIBCO BRL. pcDNA-1/Neo was from Invitrogen. ICI 118551 and nitrendipine were from Research Biochemicals, Inc. CGP20712 was a gift from CIBA-GEIGY. All other reagents were from Sigma Chemical Co.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Properties of Expressed Ca2+ Channels
Cotransfection of BHK cells with cDNAs encoding the rabbit cardiac {alpha}1 and skeletal {alpha}2 and ß subunits resulted in easily detectable mRNA expression for each subunit (Fig 1Down). As shown, nontransfected BHK cells do not express detectable mRNA for these subunits. Expression and function of Ca2+ channels in BHKC112 cells was further assessed by radioligand binding using the DHP antagonist [3H]PN 200-110 and by patch-clamp techniques as described below. Saturation binding studies revealed a Kd of 0.81±0.23 nmol/L (n=3, Fig 2Down), in good general agreement with binding affinities observed in endogenous myocardial channels.31 The density of L-type Ca2+ channels in membranes prepared from transfected BHK cells was 1227±199 fmol/mg protein (n=7). Nontransfected BHK cells did not display any specific [3H]PN 200-110 binding sites (data not shown).



View larger version (45K):
[in this window]
[in a new window]
 
Figure 1. Northern analysis of baby hamster kidney (BHK) cells (lanes 1, 2, 5, 6, 9, and 10) and transfected recombinant cardiac Ca2+ channel BHK cells (lanes 3, 4, 7, 8, 11, and 12). Total RNA (5 µg) was electrophoresed, transferred to nylon membranes, and individually hybridized with double-stranded cDNA probes for the {alpha}1, {alpha}2, and ß Ca2+ channel subunits as described in "Materials and Methods." Autoradiograms were exposed at -70°C for 72 hours before developing. Lanes are as follows: 1 through 4, {alpha}1 probe; 5 through 8, {alpha}2 probe; and 9 through 12, ß probe. Equivalent loading of RNA was confirmed by using a double-stranded actin probe, which gave a strong signal in all lanes (not shown).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 2. Graph showing saturation binding of membranes from baby hamster kidney cells expressing L-type Ca2+ channel. Membranes were prepared as described in "Materials and Methods" and incubated with [3H]PN200-110 in the presence ({diamondsuit}) or absence ({circ}) of 1 µmol/L nitrendipine for 2 hours at room temperature. Reactions were stopped by dilution and rapid filtration over glass fiber filters before being counted in a scintillation counter. Nonlinear regression of specific binding ({bullet}) yielded a Kd of 0.49 nmol/L. Data shown are representative of three experiments, each performed in duplicate.

Voltage-activated Ca2+ channel currents were measured in the presence of 2 mmol/L Ba2+ (Fig 3Down). Nontransfected BHK cells did not demonstrate voltage-activated inward Ba2+ current (IBa) (Fig 3ADown), in agreement with radioligand binding data. In contrast, BHKC112 cells expressed large inward IBa, which inactivated slowly during 300-millisecond depolarizing pulses (Fig 3BDown). The size of peak inward IBa was 861±117 pA (n=60; range, 110 to 3100 pA). The whole-cell current properties were further analyzed by using cells expressing current densities <1000 pA in order to avoid series resistance artifacts associated with large current amplitude (TableDown).



View larger version (27K):
[in this window]
[in a new window]
 
Figure 3. Typical whole-cell currents recorded in baby hamster kidney (BHK) cells (A) in the presence of 20 mmol/L Ba2+ and in recombinant cardiac Ca2+ channel BHK (BHKC112) cells (B) in the presence of 2 mmol/L Ba2+ as the charge carrier. Tracings show currents recorded from a holding potential of -80 mV to indicated test potentials. The normalized conductance (G/Gmax)–voltage curve for the BHKC112 cell shown in panel B was plotted in panel C. The solid line is fit to a Boltzmann equation. The midpoint potential (V0.5) and the slope factor k are -10.9 and 3.6 mV, respectively. Panel D shows voltage-dependent inactivation of the Ba2+ current in the BHKC112 cell. The current inactivation was examined by a double-pulse protocol (inset). The cells were held at -80 mV and stepped to different membrane potentials between -100 and +20 mV in 20-mV increments for 5 seconds and then stepped to test pulse of 0 mV. Gaps between two pulses were 50 milliseconds, and double pulses were applied every 30 seconds. Panel E shows the peak current during the test pulse normalized to the maximal peak current (Ip/Ipmax). The solid line is fit to a Boltzmann equation. V0.5 and k are -35 and 9.0 mV, respectively.


View this table:
[in this window]
[in a new window]
 
Table 1. Properties of Whole-Cell Ba2+ Currents Expressed in Recombinant Cardiac Ca2+ Channel Baby Hamster Kidney Cells

The voltage dependence of current activation was determined by measuring the peak current elicited by depolarizing pulses to various potentials. Typically, the inward current activated at a threshold potential between -30 and -20 mV, peaked between -10 and 0 mV, and reversed around +50 mV. Conductance was then calculated by dividing the peak current by the driving force (Fig 3CUp and TableUp). It was difficult to estimate the true reversal potential for the Ca2+ channels, because a small outward current in nontransfected cells overlapped at positive potentials (Fig 3AUp). Therefore, the apparent reversal potential was obtained by extrapolating the peak current-voltage (I-V) plot through the zero current axis. The voltage-dependent channel inactivation was determined by applying 5-second depolarizing pulses to a series of different potentials (Fig 3DUp). V0.5 and k values were determined from a Boltzmann equation (Fig 3EUp and TableUp). These data demonstrate that the activation and inactivation kinetics of expressed currents in BHKC112 cells are comparable to the L-type Ca2+ channel seen in native cardiac myocytes.4 36 As previously reported in various cell types, we found that the Ca2+ channel currents run down after the whole-cell recording configuration has been established.3 In control experiments (n=10), we generally observed that IBa initially increased in amplitude immediately after puncturing the membrane and then exhibited rundown. During rundown, peak inward current amplitude decreased by 50% at a steady rate over 20 to 30 minutes.

The pharmacological properties of the channels expressed in BHKC112 cells are shown in Fig 4Down. The DHP-agonist Bay K 8644 increased IBa in a concentration-dependent manner with an average EC50 of 80 nmol/L (n=4, Fig 4ADown). As in the case of native cardiac cells, Bay K 8644 (1 µmol/L) shifted the I-V curve to more negative potentials by 11.5±1.3 mV. The benzothiazepine Ca2+ channel blocker diltiazem reversibly reduced IBa with an average IC50 of 5 µmol/L (n=4, Fig 4BDown), without changing the I-V relations. Diltiazem at 5 µmol/L shifted the voltage-dependent inactivation curves to more negative potentials by 14.8±1.4 mV.



View larger version (11K):
[in this window]
[in a new window]
 
Figure 4. Effects of 1 µmol/L Bay K 8644 (A) and 10 µmol/L diltiazem (B) on Ba2+ current (IBa) in the recombinant cardiac Ca2+ channel baby hamster kidney cell. Current tracings show superimposed IBa before and after the application of the agents. Depolarizing pulses to -10 mV (A) or 0 mV (B) were applied from a holding potential of -80 mV. Bars=100 milliseconds and 200 pA.

To examine the effects of cAMP-dependent phosphorylation on these recombinant Ca2+ channel currents, a membrane-permeable cAMP analogue, dibutyryl cAMP (dB-cAMP), was applied to the cells. In the presence of dB-cAMP (50 µmol/L), the amplitude of IBa gradually increased and reached a new steady state level {approx}3 minutes after application (Fig 5ADown). Neither the voltage-dependent activation nor inactivation was significantly affected by dB-cAMP exposure (Fig 5BDown). An average increase in IBa of 22.9±5.6% was observed in seven cells of the 14 studied. The reasons for the failures of {approx}50% of the experiments are not known. As noted above, in most of the cells, IBa declines gradually in control conditions. Thus, the varied effects after dB-cAMP treatment are probably due to competition between the slow increase in IBa due to dB-cAMP and the steady decrease of control current. The membrane currents in nontransfected BHK cells were not affected by the addition of dB-cAMP (n=10). Together, these results indicate that increased levels of intracellular cAMP potentiate Ca2+ channel currents expressed in BHKC112 cells.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 5. Modulation of Ba2+ current in the recombinant cardiac Ca2+ channel baby hamster kidney cell by dibutyryl cAMP (dB-cAMP, 50 µmol/L). Current tracings (A) are shown before (left) and 5 minutes after (right) dB-cAMP in response to the test potential indicated. The holding potential was -80 mV. The corresponding peak current-voltage relations are plotted in panel B. Bars=100 milliseconds and 100 pA.

Fig 6Down shows single-channel recordings of BHKC112 cells in the presence of 1 µmol/L Bay K 8644. Single-channel data obtained from cell-attached patches also demonstrated the features of native cardiac L-type Ca2+ channels. For example, the open-state probability of the channel increased with depolarization (Fig 6ADown). From the I-V relations of unitary Ba2+ currents, a single-channel conductance of 24 pS was estimated (Fig 6BDown). This value correlates well with the value of 24 to 25 pS observed in cardiac myocytes that was determined under identical conditions.37 38 From whole-cell and single-channel measurements (Figs 4AUp and 6BDown), we estimated the Ca2+ channel density in BHKC112 cells, assuming a probability of opening of 0.2 at 0 mV and a unitary current amplitude of 1.1 pA, to be {approx}2700 channels per cell, or about three channels per square micrometer.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 6. Single-channel currents recorded from the cell-attached patch on the recombinant cardiac Ca2+ channel baby hamster kidney cell. A, Typical single-channel current evoked by step pulses to indicated voltages from a holding potential of -80 mV in the presence of Bay K 8644 (1 µmol/L). B, Current-voltage relations of single-channel currents. The solid line is linear regression with a slope conductance of 24 pS. Each data point is the mean from four to six experiments with 100 to 1000 events.

Functional Coupling of Ca2+ Channel Currents With Coexpressed ß1ARs
We transiently transfected the ß1AR cDNA into BHKC112 cells and determined receptor expression by radioligand binding. Nontransfected BHKC112 cells expressing only the DHP-sensitive Ca2+ channel demonstrated no detectable ICYP binding (data not shown). In contrast, membranes from BHKC112 cells transfected with pcNeoß1, as described in "Materials and Methods," expressed {approx}200 fmol ICYP binding sites per milligram protein (range, 150 to 300 fmol/mg). It should be noted that because of the transient nature of these transfections, only a portion of BHKC112 cells treated in this manner actually take up and express the ß1AR; as a result, the receptor density obtained by radioligand binding represents a mean value for all cells treated, including those cells that failed to take up exogenous DNA. Our previous experience with these assays has suggested that the actual efficiency of transient expression (ie, the proportion of total cells that express the recombinant protein of interest) is between 30% and 60% (S.A. Green and S.B. Liggett, unpublished data, 1994). As described in detail below, we noted electrophysiological evidence of ß1AR activity in 32 of 78 cells studied, a figure that is consistent with this phenomenon.

The identity and functional nature of the expressed ßAR was confirmed as the ß1AR subtype by competition binding and cAMP determinations. As depicted in Fig 7ADown, membranes prepared from BHKC112 cells transfected with pcNeoß1 demonstrated rank-order antagonist profiles typical of ß1AR receptors.28 In addition, transfection of pcNeoß1 conferred Iso responsiveness for cAMP accumulation in whole cells, which was not observed in nontransfected BHKC112 cells (Fig 7BDown). This response confirms the presence of ß1AR functionally coupled to the Gs/adenylyl cyclase pathway.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 7. Graphs showing pharmacological characteristics of recombinant cardiac Ca2+ channel baby hamster kidney (BHKC112) cells transfected with pcNeoß1. A, Antagonist competition binding with [125I]cyanopindolol ([125I]CYP) performed in membranes prepared from transfected cells as described in "Materials and Methods." Nonlinear regression of binding data yielded Ki values of 1.91 and 114 nmol/L for CGP 20712 (ß1-specific antagonist) and ICI 118 551 (ß2-specific antagonist), respectively. B, Accumulation of cAMP in response to isoproterenol. cAMP content in intact BHKC112 cells was determined by radioimmunoassay along with that observed in cells transfected with pcNeoß1, as described in "Materials and Methods." Nonlinear regression yielded an EC50 value for isoproterenol-promoted cAMP accumulation of 2.9 nmol/L. Data shown are representative of two experiments, with each point determined in duplicate. ß1AR indicates ß2-adrenoceptor.

Potentiation of IBa in BHKC112 cells transfected with the ß1AR was examined with various concentrations of Iso. An increase in IBa was detectable with 10 nmol/L Iso and reached a maximum at {approx}10 µmol/L. As noted above, an effect of Iso on IBa was observed in 32 of 78 cells transfected with the pcNeoß1. An increase in the Ca2+ channel currents by Iso was not observed in BHKC112 cells not transfected with the ß1AR (n=24), consistent with the lack of ßAR measured by the radioligand binding.

During the steady state exposure to Iso at a concentration of 10 µmol/L, the mean relative increase of IBa by Iso (10 µmol/L) was 2.39±0.35-fold (n=12, Fig 8ADown and 8BDown). Several studies have reported that the ß-adrenergic stimulation of Ca2+ channel currents causes a shift in the I-V curve to more negative potentials.39 40 Therefore, we examined the effects of Iso on the I-V relation of IBa. The peak I-V relations before and after Iso exposure are illustrated in Fig 8DDown. Iso increased IBa at all potentials measured without changing the peak I-V relation. In four experiments, the conductance-voltage relation was analyzed in the same way as described in Fig 3CUp. In the absence of Iso, the mean values of V0.5 and k were -6.8±3.5 and 4.5±0.6 mV. With 10 µmol/L Iso, the values were -8.5±3.9 and 4.4±0.7 mV for V0.5 and k, respectively. These results indicate that ß1-adrenoceptor stimulation did not affect the voltage-dependent activation kinetics. In most experiments, such as that depicted in Fig 8CDown, the current waveform appeared to be scaled, suggesting that the time course of IBa was not altered by Iso. Fig 8EDown depicts the dose-response relations for Iso on IBa. Analysis of data by nonlinear techniques using a one-to-one drug-receptor relation revealed a mean EC50 of 231 nmol/L (n=5). Iso-mediated increases in IBa were completely inhibited by 50 µmol/L propranolol (data not shown).



View larger version (27K):
[in this window]
[in a new window]
 
Figure 8. Effects of isoproterenol (Iso) on Ba2+ current (IBa) in recombinant cardiac Ca2+ channel baby hamster kidney cells expressing the ß1-adrenoceptor (ß1AR). Currents recorded before (A) and 2 minutes after (B) the applications of Iso (10 µmol/L) are shown. Holding potential was -80 mV. The control current at 0 mV was scaled for comparison with the waveform in panel C. Current-voltage relations (D) are shown in the absence and presence of Iso (same data as shown in panels A and B). Concentration-response curve (E) is shown for the effect of Iso on IBa. The relative increase of peak current amplitude at different Iso concentrations was obtained by normalizing to the value produced by the drug (10 µmol/L). Solid line is fit to one-to-one binding model with an EC50 of 231 nmol/L. Data are the mean from four experiments.

The degree of increase in IBa by Iso was dependent on the presence of guanine nucleotides; without GTP in the pipette solution, in the presence of 10 µmol/L Iso, the magnitude of enhancement was greatly reduced to 106±3% of control values (n=5). To further test the involvement of a G protein pathway in the potentiation of Ca2+ channel currents, cells were loaded with the nonhydrolyzable GDP analogue GDPßS instead of GTP in the patch pipette and were then depolarized from a holding potential of -80 to 0 mV every 10 seconds for 5 minutes. The relative current amplitudes of IBa during this time were reduced by {approx}15% to 20% (n=4). No increase in IBa was observed after application of 10 µmol/L Iso, and the time course of the current amplitude was indistinguishable from that in the control experiments.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
A number of neurotransmitters modulate cardiac L-type Ca2+ channel currents through G protein–coupled receptors, including various {alpha}-adrenergic, ß-adrenergic, and muscarinic receptor subtypes.41 Because of the coexistent expression of different receptor subtypes with overlapping affinities for commonly used agonists and antagonists, separation of subtype-specific effects on native L-type Ca2+ channels is frequently problematic. To examine the relative functional coupling of a particular receptor subtype to Ca2+ channels, experiments should ideally be performed with tissue or cells expressing pure populations of the receptor of interest. To address this, we stably expressed cardiac L-type Ca2+ channels in a mammalian cell line and subsequently examined the effects of transiently expressed ß1ARs on the Ca2+ channel regulation.

Our results indicate that this mammalian cell recombinant system can provide a useful tool that may be superior to the commonly used oocyte system for studying the regulation of Ca2+ channels. The expression of Ca2+ channel currents in this clonal cell line has been stable over extended periods with reproducible results. This may avoid some of the technical limitations associated with the oocyte expression system, including seasonal variability in oocyte quality and time constraints imposed by the transient expression system. Compared with oocytes, BHK cells have a smaller size and offer improved voltage-clamp quality for biophysical analysis of the channel. In addition, Ca2+ channels expressed in mammalian cells may undergo posttranslational modifications and regulation processes in a manner more akin to that occurring in native cells. For example, each {alpha}1 subunit has multiple consensus sites for phosphorylation by PKA. In mammalian cells, phosphorylation of the cardiac Ca2+ channel {alpha}1 subunit by cAMP increases Ca2+ channel currents,15 16 but Ca2+ channel currents expressed in oocytes are not modulated by cAMP.14

Previous studies have shown that expression of cardiac or smooth muscle Ca2+ channel {alpha}1 subunit alone in CHO cells produces functional DHP-sensitive Ca2+ channel currents.15 42 43 The DHP sensitivity, high voltage–dependent activation, and single-channel conductance of these channel subunits are similar to those observed in native cells. However, whole-cell recordings revealed some differences in their biophysical properties. For example, expressed channels displayed slower rates of activation and inactivation than those observed in native cells. Coexpression of the {alpha}1 subunit with Ca2+ channel ß and {alpha}2/{delta} subunits from skeletal muscle in CHO cells increased the current density and DHP-binding sites mediated by the {alpha}1 subunit.43 In addition, the coexpression produced rapid activation and inactivation rates and shifts in the steady state activation and inactivation to more negative potentials.

Therefore, in the present study, we expressed the cardiac Ca2+ channel {alpha}1 subunit in combination with the skeletal ß and {alpha}2/{delta} subunits to produce high-level expression and native cell–like channel kinetics. BHK cells transfected with the cDNAs of the {alpha}1, ß, and {alpha}2/{delta} subunits demonstrated specific high-affinity [3H]PN200-110 binding with a Kd of 0.81 nmol/L, a Bmax of 1230 fmol/mg protein, and a current density measured in the presence of 2 mmol/L Ba2+ of 19.45 A/F. These values are comparable to those obtained in CHO cells expressing Ca2+ channel {alpha}1, ß, and {alpha}2 subunits.43 Furthermore, the Ca2+ channels expressed in BHKC112 cells exhibit pharmacology, channel kinetics, and single-channel conductances characteristic of native cardiac L-type Ca2+ channels.

Native cardiac Ca2+ channels are phosphorylated by PKA, although the primary target subunit(s) for phosphorylation is unclear.13 It has been previously shown that CHO cells expressing cardiac Ca2+ channel {alpha}1 subunits alone are phosphorylated by membrane-permeable cAMP or intracellular PKA.15 16 We found that dB-cAMP increases IBa to an extent similar to that observed in CHO cells.15 Recently Perez-Reyes et al44 have reported that IBa in human embryonic kidney (HEK) cells expressing cardiac L-type Ca2+ channel {alpha}1 and ß subunits did not increase by phosphorylation unless endogenous kinases were previously inhibited. Our observation that phosphorylation of Ca2+ channels expressed in BHKC112 cells leads to stimulation of IBa comparable to the phosphorylation of CHO cells indicates that the basal phosphorylation of BHKC112 cells is rather low compared with HEK cells. Although this observation does not definitely establish the {alpha}1 subunit as the sole target protein for phosphorylation under our experimental conditions, the presence of a cAMP-regulated component in the complete channels expressed in BHKC112 cells supports the use of this system for studying regulatory mechanisms controlling Ca2+ channel activity.

As noted in the present study, Ca2+ channel currents in BHKC112 cells not transfected with the human ß1AR are not responsive to the external application of Iso. In agreement with these results, radioligand binding studies did not reveal measurable ßARs. Coexpression with ß1AR rendered the cell responsive to Iso. The ß1AR modulation of the recombinant cardiac Ca2+ channels by Iso is remarkably similar to that observed in native cardiac myocytes.1 3 4 The external application of Iso produced a concentration-dependent enhancement of Ca2+ channel current amplitudes. In contrast to the results of previous studies,1 3 4 several recent reports indicate that the Iso stimulation of Ca2+ channel currents causes changes in the voltage-dependent Ca2+ channel gating.39 40 In our experiments, potentiation of the current amplitude by Iso occurred at all membrane potentials, and the current waveform during depolarization was not affected by Iso, suggesting that the voltage-dependent parameters were not affected. The reasons for these differences are not clear. One possible explanation, however, is the contribution of other ßAR subtypes that may be present in native cells. For example, Xiao and Lakatta9 have noted that there are differences between ß1AR and ß2AR stimulation in their effects on Ca2+ channel currents; ß2AR but not ß1AR stimulation markedly prolonged the Ca2+ channel current inactivation time.

The maximum increase in the current amplitude by Iso in BHKC112 cells was close to that observed in mammalian cardiac myocytes.1 3 4 40 The maximum increase was a factor of 3 to 4; however, the EC50 value ({approx}200 nmol/L) in BHKC112 cells was higher than that seen in native cells ({approx}38 nmol/L). The reason for this discrepancy is not clear. It is possible that an additional cofactor involved in ß1AR/Ca2+ channel coupling is not present in BHK cells. However, other cellular components necessary for the signal transduction, such as G proteins and adenylyl cyclase, are clearly present, as indicated by our studies of cAMP accumulation. The differences may therefore reflect coupling characteristics specific to ß1ARs. Recent pharmacological studies using mammalian cell lines that express ß1AR or ß2AR exclusively indicate that these subtypes mediate quantitatively different effects on Gs–adenylyl cyclase coupling.28 45 For example, Green et al28 found that although both receptors mediated equivalent maximal increases in Iso-stimulated adenylyl cyclase activities, the EC50 for the ß2AR was significantly lower than that for the ß1AR. Therefore, it is possible that the lower EC50 observed for Iso increases in IBa in endogenous myocytes may in fact reflect a contribution from the ß2AR that is not seen in our recombinant system. Further study will be necessary to clarify this relation.

In summary, our results show that heterologous expression in mammalian cells provides a useful system for studying functional properties of a Ca2+ channel protein. It is hoped that this system will facilitate the study of the receptor-mediated regulation of Ca2+ channel activities.


*    Acknowledgments
 
This study was supported by American Heart Association Grant-in-Aid 93012860 (Dr Yatani). Dr Wakamori is a fellow supported by the International Human Frontier Science Foundation. The authors would like to thank Drs S. Liggett and A. Schwartz for encouragement and guidance throughout this work. The authors also thank Dr Piotr Chomczynski for performing the Northern analysis and Dr J. Heiny for critical review of the manuscript.

Received May 31, 1994; accepted November 9, 1994.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Kameyama M, Hofmann F, Trautwein W. On the mechanism of ß-adrenergic regulation of the Ca channel in the guinea-pig heart. Pflugers Arch. 1985;405:285-293. [Medline] [Order article via Infotrieve]

2. Imoto Y, Yatani A, Reeves JP, Codina J, Birnbaumer L, Brown AM. The {alpha}-subunit of Gs directly activates cardiac calcium channels in lipid bilayers. Am J Physiol. 1988;255:H722-H728. [Abstract/Free Full Text]

3. Yatani A, Brown AM. Rapid ß-adrenergic modulation of cardiac calcium currents by a fast G protein pathway. Science. 1989;245: 71-74.

4. Hartzell HC. Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems. Prog Biophys Mol Biol. 1988;52:165-247. [Medline] [Order article via Infotrieve]

5. Pelzer S, Shuba YM, Asai T, Codina J, Birnbaumer L, McDonald TF, Pelzer D. Membrane-delimited stimulation of heart cell calcium current by ß-adrenergic signal-transducing Gs protein. Am J Physiol. 1990;259:H264-H267. [Abstract/Free Full Text]

6. Hartzell HC, Fischmeister R. Direct regulation of cardiac Ca2+ channels by G proteins: neither proven nor necessary? Trends Pharmacol Sci. 1992;13:380-385. [Medline] [Order article via Infotrieve]

7. Motomura S, Zerkowski H-R, Daul A, Brodde O-E. On the physiologic role of beta-2 adrenoceptors in human heart: in vitro and in vivo studies. Am Heart J. 1990;119:609-619.

8. Dukes ID, Vaughan Williams EM. Effects of selective {alpha}1-, {alpha}2-, ß1- and ß2-adrenoceptor stimulation on potentials and contractions in the rabbit heart. J Physiol (Lond). 1984;355:523-546. [Abstract/Free Full Text]

9. Xiao R-P, Lakatta EG. ß1-Adrenoceptor stimulation and ß2-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca2+, and Ca2+ current in single rat ventricular cells. Circ Res. 1993;73:286-300. [Abstract/Free Full Text]

10. O'Donnel SR, Wanstall JC. Responses to the ß2-selective agonist procaterol of vascular and atrial preparations with different functional ß-adrenoceptor populations. Br J Pharmacol. 1985;84: 227-235.

11. Hullin R, Biel M, Flockerzi V, Hofmann F. Tissue-specific expression of calcium channels. Trends Cardiovasc Med. 1993;3:48-53.

12. Catterall WA, Striessnig J. Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci. 1992;13:256-262. [Medline] [Order article via Infotrieve]

13. Haase H, Karczenski P, Beckert R, Krause EG. Phosphorylation of the L-type calcium channel ß-subunit is involved in ß-adrenergic signal transduction in canine myocardium. FEBS Lett. 1993;335:217-222. [Medline] [Order article via Infotrieve]

14. Klöckner U, Itagaki K, Bodi I, Schwartz A. ß-Subunit expression is required for cAMP-dependent increase of cloned cardiac and vascular calcium channel currents. Pflugers Arch. 1992;420:413-415. [Medline] [Order article via Infotrieve]

15. Yoshida A, Takahashi M, Nishimura S, Takeshima H, Kokubun S. Cyclic AMP-dependent phosphorylation and regulation of the cardiac dihydropyridine-sensitive Ca channel. FEBS Lett. 1992;309:343-349. [Medline] [Order article via Infotrieve]

16. Sculptoreau A, Rotman E, Takahashi M, Scheuer T, Catterall WA. Voltage-dependent potentiation of the activity of cardiac L-type calcium channel {alpha}1 subunits due to phosphorylation by cAMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1993;90: 10135-10139.

17. Singer D, Biel M, Lotan L, Flockerzi V, Hofmann F, Dascal N. The roles of the subunits in the function of the calcium channel. Science. 1991;253:1553-1557. [Abstract/Free Full Text]

18. Williams ME, Brust PF, Feldman DH, Patthi S, Simerson S, Maroufi A, McCue AF, Veligebi G, Ellis SB, Harpold MM. Structure and functional expression of an {omega}-conotoxin-sensitive human N-type calcium channel. Science. 1992;257:389-395. [Abstract/Free Full Text]

19. Lory P, Nargeot J. Cyclic AMP-dependent modulation of cardiac Ca channels expressed in Xenopus laevis oocytes. Biochem Biophys Res Commun. 1992;182:1059-1065. [Medline] [Order article via Infotrieve]

20. Yatani A, Wakamori M, Mikala G, Bahinski A. Block of transient outward-type cloned cardiac K+ channel currents by quinidine. Circ Res. 1993;73:351-359. [Abstract/Free Full Text]

21. Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, Narumiya S, Numa S. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature. 1989;340:230-233. [Medline] [Order article via Infotrieve]

22. Ruth P, Röhrkasten A, Biel M, Bosse E, Regulla S, Meyer HE, Flockerzi V, Hofmann F. Primary structure of the ß subunit of the DHP-sensitive calcium channel from skeletal muscle. Science. 1989;245:1115-1118. [Abstract/Free Full Text]

23. Waechter DE, Baserga R. Effect of methylation on expression of microinjected genes. Proc Natl Acad Sci U S A. 1982;79:1106-1110. [Abstract/Free Full Text]

24. Kaufman RJ, Sharp PA. Construction of a modular dihydrofolate reductase cDNA gene: analysis of signals utilized for efficient expression. Mol Cell Biol. 1982;2:1304-1319. [Abstract/Free Full Text]

25. O'Hare K, Benoist C, Breathnach R. Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase. Proc Natl Acad Sci U S A. 1981;78:1527-1531. [Abstract/Free Full Text]

26. Fukuda K, Higashida H, Kubo T, Maeda A, Akiba I, Bujo H, Mishina M, Numa S. Selective coupling with K+ currents of muscarinic acetylcholine receptor subtypes in NG108-15 cells. Nature. 1988;335:355-358. [Medline] [Order article via Infotrieve]

27. Mishina M, Kurosaki T, Robimatsu T, Morimoto Y, Noda M, Yamamoto T, Terao M, Lindstrom J, Takahashi T, Kuno M, Numa S. Expression of functional acetylcholine receptor from cloned cDNAs. Nature. 1984;307:604-608. [Medline] [Order article via Infotrieve]

28. Green SA, Holt BD, Liggett SB. ß1- and ß2-adrenergic receptors display subtype-selective coupling to Gs. Mol Pharmacol. 1992;41:889-893. [Abstract]

29. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159. [Medline] [Order article via Infotrieve]

30. Mori Y, Friedich T, Kim M-S, Mikami A, Nakai J, Ruth P, Bosse E, Hofmann F, Flockerzi V, Furuichi T, Mikoshiba K, Imoto K, Tanabe T, Numa S. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature. 1991;350:394-402.

31. Hamilton SL, Yatani A, Brush K, Schwartz A, Brown AM. A comparison between binding and electrophysiological effects of dihydropyridines on cardiac membranes. Mol Pharmacol. 1987;31:221-231. [Abstract]

32. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76-85. [Medline] [Order article via Infotrieve]

33. Liggett SB, Bouvier M, Hausdorff WP, O'Dowd B, Caron MG, Lefkowitz RJ. Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant ß2-adrenergic receptors lacking phosphorylation sites. Mol Pharmacol. 1989;36:641-646. [Abstract]

34. Yatani A, Okabe K, Birnbaumer L, Brown AM. Detergents, dimeric Gß{gamma}, and eicosanoid pathways to muscarinic atrial K+ channels. Am J Physiol. 1990;258:H1507-H1514. [Abstract/Free Full Text]

35. Nakagawa T, Shirasaki T, Wakamori M, Fukuda A, Akaike N. Excitatory amino acid response in isolated nucleus tractus solitari neurons of the rat. Neurosci Res. 1990;8:114-123. [Medline] [Order article via Infotrieve]

36. Bean BP. Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology. J Gen Physiol. 1985;86:1-30. [Abstract/Free Full Text]

37. Kokubun S, Reuter H. Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. Proc Natl Acad Sci U S A. 1984;81:4824-4827. [Abstract/Free Full Text]

38. Yatani A, Codina J, Imoto K, Reeves JP, Birnbaumer L, Brown AM. A G protein directly regulates mammalian cardiac calcium channels. Science. 1987;238:1288-1292. [Abstract/Free Full Text]

39. Bean BP, Mowycky MC, Tsien RW. ß-Adrenergic modulation of calcium channels in frog ventricular heart cells. Nature. 1984;307:371-375. [Medline] [Order article via Infotrieve]

40. Tiaho F, Nargeot J, Richard S. Voltage-dependent regulation of L-type cardiac Ca channels by isoproterenol. Pflugers Arch. 1991;419:596-602. [Medline] [Order article via Infotrieve]

41. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem. 1991;60:653-688. [Medline] [Order article via Infotrieve]

42. Bosse E, Bottlender R, Kleppisch T, Hescheler J, Welling A, Hofmann F, Flockerzi V. Stable and functional expression of the calcium channel {alpha}1 subunit from smooth muscle in somatic cell lines. EMBO J. 1992;11:2033-2038. [Medline] [Order article via Infotrieve]

43. Welling A, Bosse E, Cavalié A, Bottlender R, Ludwig A, Nastainczyk W, Flockerizi V, Hofmann F. Stable co-expression of calcium channel, {alpha}1, ß and {alpha}2/{delta} subunits in a somatic cell line. J Physiol (Lond). 1993;471:749-765. [Abstract/Free Full Text]

44. Perez-Reyes E, Yuan W, Wei X, Bers DM. Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase. FEBS Lett. 1994;342:119-123. [Medline] [Order article via Infotrieve]

45. Levy FO, Zhu X, Kaumann J, Birnbaumer L. Efficacy of ß1-adrenergic receptors is lower than that of ß2-adrenergic receptors. Proc Natl Acad Sci U S A. 1993;90:10798-10802.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Circ. Res.Home page
J. Miriyala, T. Nguyen, D. T. Yue, and H. M. Colecraft
Role of CaV{beta} Subunits, and Lack of Functional Reserve, in Protein Kinase A Modulation of Cardiac CaV1.2 Channels
Circ. Res., April 11, 2008; 102(7): e54 - e64.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. T. Hulme, R. E. Westenbroek, T. Scheuer, and W. A. Catterall
Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation
PNAS, October 31, 2006; 103(44): 16574 - 16579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Qu, G. Baroudi, Y. Yue, N. El-Sherif, and M. Boutjdir
Localization and modulation of {alpha}1D (Cav1.3) L-type Ca channel by protein kinase A
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2123 - H2130.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Erxleben, C. Gomez-Alegria, T. Darden, Y. Mori, L. Birnbaumer, and D. L. Armstrong
Modulation of cardiac CaV1.2 channels by dihydropyridine and phosphatase inhibitor requires Ser-1142 in the domain III pore loop
PNAS, March 4, 2003; 100(5): 2929 - 2934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. D. Keef, J. R. Hume, and J. Zhong
Regulation of cardiac and smooth muscle Ca2+ channels (CaV1.2a,b) by protein kinases
Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1743 - C1756.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Mochly-Rosen, G. Wu, H. Hahn, H. Osinska, T. Liron, J. N. Lorenz, A. Yatani, J. Robbins, and G. W. Dorn II
Cardiotrophic Effects of Protein Kinase C {epsilon} : Analysis by In Vivo Modulation of PKC{epsilon} Translocation
Circ. Res., June 9, 2000; 86(11): 1173 - 1179.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. Lehmann-Horn and K. Jurkat-Rott
Voltage-Gated Ion Channels and Hereditary Disease
Physiol Rev, October 1, 1999; 79(4): 1317 - 1372.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. W. Dorn II, N. M. Tepe, J. N. Lorenz, W. J. Koch, and S. B. Liggett
Low- and high-level transgenic expression of beta 2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galpha q-overexpressing mice
PNAS, May 25, 1999; 96(11): 6400 - 6405.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Wakamori, M. Strobeck, T. Niidome, T. Teramoto, K. Imoto, and Y. Mori
Functional Characterization of Ion Permeation Pathway in the N-Type Ca2+ Channel
J Neurophysiol, February 1, 1998; 79(2): 622 - 634.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yatani, A.
Right arrow Articles by Green, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yatani, A.
Right arrow Articles by Green, S.